Drug intelligence / Profile preview

rizatriptan + acetaminophen

Development stage
Preclinical
Lead developer
Merck
Modality
Small Molecules
Administration
Oral
01

Overview

Rizatriptan + acetaminophen is a combination therapy used for the acute treatment of migraine headaches. Rizatriptan is a selective serotonin 5-HT1B/1D receptor agonist (triptan) that works by narrowing blood vessels in the brain, inhibiting pain signal transmission, and blocking the release of substances that cause migraine symptoms. Acetaminophen is an analgesic and antipyretic agent commonly used to relieve mild to moderate pain and reduce fever. The rationale for combining these agents lies in their complementary mechanisms—rizatriptan targets central neurovascular pathways specific to migraines, while acetaminophen provides general analgesia through central inhibition of prostaglandin synthesis. Clinical studies have shown that coadministration can be more effective than acetaminophen or placebo alone for rapid pain relief in acute migraine attacks[5]. This combination has not demonstrated clear superiority over rizatriptan monotherapy but may offer benefit as part of multi-mechanism therapy.

Other names
Rizatriptan and AcetaminophenRizatriptan co-administered with Acetaminophen
02

Targets

HTR1B (5-Hydroxytryptamine Receptor 1B)HTR1D (5-hydroxytryptamine receptor 1D)COX

Beyond the preview

Go deeper on rizatriptan + acetaminophen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on rizatriptan + acetaminophen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call